Shares of Aethlon Medical, Inc. (NASDAQ:AEMD) have received an average broker rating score of 1.00 (Strong Buy) from the one brokers that provide coverage for the stock, Zacks Investment Research reports.
Analysts have set a one year consensus price target of $6.25 for the company and are anticipating that the company will post ($0.08) earnings per share for the current quarter, according to Zacks. Zacks has also assigned Aethlon Medical an industry rank of 36 out of 256 based on the ratings given to related companies.
Separately, ValuEngine lowered Aethlon Medical from a “buy” rating to a “hold” rating in a report on Thursday, August 1st.
NASDAQ AEMD traded down $0.02 on Friday, hitting $0.26. 11,896 shares of the stock traded hands, compared to its average volume of 180,587. The stock’s fifty day simple moving average is $0.32. Aethlon Medical has a 12 month low of $0.20 and a 12 month high of $1.74. The company has a market cap of $4.49 million, a price-to-earnings ratio of -0.76 and a beta of 1.20.
Aethlon Medical (NASDAQ:AEMD) last announced its quarterly earnings data on Monday, July 1st. The medical equipment provider reported ($0.09) earnings per share for the quarter, missing the consensus estimate of ($0.08) by ($0.01). The business had revenue of $0.08 million during the quarter, compared to analyst estimates of $0.08 million. On average, equities analysts forecast that Aethlon Medical will post -0.27 earnings per share for the current year.
About Aethlon Medical
Aethlon Medical, Inc, a medical device company, focuses on creating devices that address unmet medical needs in health and biodefense worldwide. The company is developing Aethlon Hemopurifier, a clinical-stage therapeutic device that eliminates life-threatening viruses from the circulatory system of infected individuals.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Aethlon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aethlon Medical and related companies with MarketBeat.com's FREE daily email newsletter.